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SUMMARY 
AEC (Ankyloblepharon- Ectodermal defects- Cleft lip/palate syndrome) 
syndrome is an autosomal dominant disorder mainly characterized by 
ectodermal dysplasia, skin erosions and cleft lip and/or palate.  This disorder 
is caused by missense mutation in the Sterile Alpha Motif  (SAM) domain 
of the transcription factor p63, a crucial regulator of embryonic 
development of stratified epithelia. 
To fully understand the molecular mechanisms associated with the 
pathogenesis of AEC syndrome, we have generated and characterized a 
mouse model carrying the clinically relevant L514F human mutation. 
p63
+/L514F
 mice showed a lethal phenotype due to a severe cleft of the 
secondary palate. Skin was hypoplastic and fragile recapitulating at least in 
part the phenotype observed in AEC patients. 
Gene expression analysis performed on epidermis isolated from p63
+/L514F
 
versus wild type mice, showed that only a subset of bona-fide direct targets 
of p63 were affected by the mutation at least in heterozygosity.  
To further understand the effect of the mutation on the p63 protein function, 
we crossed our chimeras carrying L514F in the germ line cells and p63
+/-
 
and we obtained p63
-/L514F
 mice. In the absence of the wild-type allele, p63
-
/L514F
 mice display a comparable phenotype to that of p63
-/-
 mice suggesting 
that mutations in the SAM domain severely affect the entire function of p63 
! protein.  
Although p63 has an important role in proliferation and differentiation of 
epidermis, we demonstrated that these two processes occurred properly in  
p63
+/L514F
. In contrast, we collected strong evidence in line with an 
III
impairment of the proliferative potential and/or survival of mutant 
epidermal stem cells. Flow cytometric analysis with stem cell surface 
markers, indicated a strong reduction in the stem cell population of mutant 
mice compared to wild-type. In addition, clonogenic analysis performed on 
keratinocytes obteined from p63
+/L514F
 and wild-type epidermis, showed a 
decrease of size and number of mutant colonies. Finally, p63
+/L514F
 
epidermis displayed low protein and mRNA levels of the skin progenitor 
cell marker Krt15 (Keratin 15). 
Furthermore, we found increased apoptosis in the basal layer of epidermis, 
where stem cells are putatively located. This finding suggested that the 
defect in epidermal stem cell compartment could be associated to a defect in 
cell survival. In conclusion, our mouse model will be useful to understand 
the pathogenesis of this complex disorder and to characterized more in 
details the identity and properties of epidermal stem cells. 
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SOMMARIO 
La sindrome AEC (Ankyloblepharon- Ectodermal defects- Cleft lip/palate 
syndrome) è una malattia autosomica dominante caratterizzata da dispasia 
ectodermica, erosioni cutanee e labioschisi e/o palatoschisi. Questo 
disordine è causato da mutazioni missenso nel dominio Sterile Alpha Motif  
(SAM) del fattore di trascrizione p63, un regolatore cruciale nello sviluppo 
embrionale degli epiteli stratificati.  
Per comprendere a pieno i meccanismi molecolari associati alla patogenesi 
della syndrome AEC, abbiamo generato e caratterizzato un modello murino 
della mutazione umana L514F, rilevante dal punto di vista clinico. I topi 
p63
+/L514F
 mostrano un fenotipo letale dovuto a grave schisi del palato 
secondario. La cute è ipoplastica e fragile ricapitolando almeno in parte il 
fenotipo osservato nei pazienti.  
L’analisi di espressione genica effettuata su epidermide isolata da  topi 
p63
+/L514F 
 e wild-type, ha mostrato che solo un sotto-gruppo di di bona-fide 
target diretti di p63 è alterata in presenza della mutazione, almeno in 
eterozigosi.  
Per comprendere ulteriormente l’effetto della mutazione sulle funzioni della 
proteina p63, abbiamo incrociato le chimere con la mutazione L514F in 
cellule della linea germinale  con topi  p63
+/-
 per ottenere topi  p63
-/L514F
.   
In assenza dell’allele wild-type, i topi p63
-/L514F
 mostrano un fenotipo 
comparabile a quello dei topi p63
-/-
suggerendo che la mutazione nel 
dominio SAM altera severamente l’intera funzione della proteina p63!.  
Sebbene p63 abbia un ruolo importante nella proliferazione e nel 
differenziamento dell’epidermide, abbiamo dimostrato che questi due 
Vprocessi avvengono correttamente nei topi p63
+/L514F
. In contrasto, abbiamo 
collezionato una serie di forte evidenze in linea con un indebolimento nel 
potenziale proliferativo e/o nella sopravvivenza delle cellule staminali 
dell’epidermide. L’ analisi citofluorimetrica con marker di superficie delle 
cellule staminali dell’epidermide, ha indicato una forte riduzione nella 
popolazione di cellule staminali nei topi mutanti rispetto ai wild-type. 
Inoltre, analisi clonogeniche effettuate su cheratinociti ottenuti da 
epidermide di topi p63
+/L514F
 e wild-type, hanno mostrato una diminuzione 
delle colonie mutanti, sia  in  numero che in dimensioni. In fine 
l’epidermide dei topi p63
+/L514F
 è caratterizzata da una riduzione dei livelli 
proteici e del mRNA di Krt15 (cheratina 15), un marker delle cellule 
progenitrici cutanee.  
Inoltre, abbiamo trovato un aumento di apoptosi nel compartimento basale 
dell’epidermide, sede delle cellule staminali. Questo risultato ci ha suggerito 
che il difetto nella popolazione di cellule staminali dell’epidermide potrebbe 
essere associato ad un difetto nella sopravvivenza cellulare. 
In conclusione, il nostro modello murino sarà utile per capire le basi 
patogenetiche di questo complesso disordine e per caratterizzare più nel 
dettaglio l’identità e le proprietà delle cellule staminali dell’epidermide. 
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1. INTRODUCTION 
 
1.1 Epidermis 
The epidermis is the outermost layer of the skin, composed of a stratified 
squamous epithelium that rests on top of a basement membrane, rich in 
extracellular matrix, which separates it and its appendages, including the 
hair follicles and sweat glands, from the underlying mesenchymally derived 
dermis. The epidermis and its appendages provide a protective barrier that 
keeps microbes out and essential body fluids in and are able to withstand the 
physical and chemical traumas.  
The epidermis is composed of 4-5 layers depending on the region of skin 
being considered. Those layers in descending order are the cornified layer 
(stratum corneum), granular layer, spinous layer and basal layer (Fig.1). The 
stratified squamous epithelium is maintained by cell division within the 
basal layer. Differentiating cells slowly displace outwards through the 
spinous layer to the stratum corneum, where anucleate corneal cells are 
continuously shed from the surface (desquamation). In normal skin the rate 
of production equals the rate of loss, taking about two weeks for a cell to 
migrate from the basal cell layer to the top of the granular cell layer, and an 
additional two weeks to cross the stratum corneum (1). 
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Figure 1. The skin and its appendages. Mammalian skin consists of the 
epidermis and dermis, separated by a basement membrane. The epidermis is 
a stratified squamous epithelium composed by: the basal layer (BL), on top 
of the basement membrane consisting of proliferating, transit- amplifying 
cells (TA) interspersed to epidermal stem cells; spinous layer (SL), granular 
layer (GL) and the stratum corneum (SC). Also shown is a cross-section of a 
hair follicle: progenitors of hair follicle reside in the portion indicated as 
bulge. (Adapted from Fuchs, Getting under the skin of epidermal 
morphogenesis, Nat Rev Genet, 2002). 
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1.2 Stem cells of epidermis 
The epidermis undergoes continual self-renewal to repair damaged tissue 
and replace old cells. To continuously renewing, skin depends on stem cells, 
which reside in the adult hair follicle, sebaceous gland and epidermis for the 
purpose of maintaining tissue homeostasis, regenerating hair and repairing 
the epidermis after injury.  
Epidermal stem cells do not possess a precise niche but are located in the 
basal layer of epidermis interspersed with cells committed to differentiation 
and are thought to proliferate at a slow rate (2). Epidermal stem cells give 
rise to a cell population with a reduced proliferative potential, named 
transit-amplifying (TA) cells. After a limited number of divisions, TA cells 
give rise to committed cells that differentiate suprabasally in mature 
keratinocytes (3). Morphological and kinetics studies showed that dorsal 
mouse skin is organized in  “epidermal proliferative units” (EPU) each 
consisting of a group of cells containing proliferative and functioning 
elements. The proliferative elements are located in the basal layer and are 
constituted by a stem cell and its progeny while the differentiated cells are 
positioned in a column (one cell wide) above the proliferative cell group (4). 
More recently another model to explain the homeostasis of epidermis has 
been proposed. This model is based on the assumption that a single type of 
progenitor cell maintains the epidermis. In this study, the authors posit that 
all proliferative cells in the basal layer might be functionally equivalent, 
such that epidermal progenitor cells give rise directly to committed spinous 
cells without entering a TA phase (5). Thus, the identity of stem cells in the 
epidermis remains to be fully established. 
It was been reported that epidermal stem cells can be distinguished from 
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other basal cells by using two markers. Immunofluorescence studies showed 
that putative stem cells expressed high levels of !6 (also named CD49f) and 
!1 integrins and, in addition, low levels of transferring receptor (also named 
CD71) (6, 7). 
However, most of the genes that are associated with skin epithelial stem 
cells are also expressed, although at lower level, in the transit-amplifying 
cells, which raises the question of whether these markers function to 
maintain stem-cell character or proliferative capacity. An example of this is 
p63, a p53 homologue that is expressed throughout the basal layer of the 
epidermis. Mutations in p63 gene are causative of several syndromes 
including the AEC syndrome that is object of this project. 
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1.3 Structure and function of p63 protein 
The p63 gene is a homologue of the archetypal tumor suppressor gene p53 
(8-12). It consists of 16 exons located on chromosome 3q28. At least six 
different protein isoforms can be produced, due to two different promoter 
sites and three different splicing routes. The amino-terminal ends are called 
TA and !N, and at the carboxy-terminal end, ", # and $ termini can be 
synthesized (Fig.2). Several functional domains have been identified. The 
central DNA-binding domain and isomerization domain are present in all 
p63 isoforms. The canonical transcription activation (TA) domain is located 
at the amino-terminal end of the TAp63 isoforms. The !N-isoforms also 
contain an amino-terminal transactivation domain (13, 14). The carboxy-
terminal end has two additional domains: the sterile-alpha-motif (SAM) 
domain and a transactivation inhibitory (TI) domain, which are both only 
present in the largest carboxy-terminal p63 " variant (Fig.2) (15).     
 
 
 
Figure 2. Schematic illustration of !N and TA p63 isoforms. Exons are 
represented by rectangles encoding the transactivation domain (blue), the 
DNA binding domain (red), the oligomerization domain (green) and the 
steril " motif (light grey) followed by the transactivation inhibitory domain 
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(encoded by the C-terminal part of exon 14) (Adapted from Keyes et al, p63 
heterozygous mutant mice are not prone to spontaneous or chemically 
induced tumors, PNAS, 2006) 
 
p63, p53 and the third member p73, constitute a family of key 
transcriptional regulators in cell growth, differentiation and apoptosis. 
While p53 is a major player in tumorigenesis (16), p63 and p73 appear to 
have pivotal roles in embryonic development (17-19).  
More in detail, p63 has a crucial role in embryonic development of stratified 
epithelia. The more abundant isoform !Np63" is expressed from cells of 
the basal layer of epidermis (12). 
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1.4 Phenotype of p63-deficient mice 
Mice lacking all p63 isoforms shed light on the crucial role of p63 in the 
development of ectodermal derived tissues; indeed p63
-/- 
mice die at birth 
and show severe developmental abnormalities, including limb truncations, 
and defects in the epidermis and its appendages (17, 18). The surface 
epithelium is thin, lacks stratification, and does not express markers of 
epithelial differentiation. Ectodermal organs such as hairs, whiskers, teeth 
and several glands, including mammary, salivary and lacrimal glands, are 
lacking (Fig. 3A-B). The epithelial phenotype has been interpreted to result 
from either lack of commitment of the immature ectoderm to epidermal 
lineages (17), or  lack of proliferative potential of the p63-deficient 
epidermal stem cells (18) (Fig. 3C).  
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Figure 3. Phenotype of p63
-/-
 mice. A. p63 mice on postnatal day1 (P1) 
have hypoplastic upper and lower jaws, and have no eyelids, whisker pads, 
skin and related appendages, which are present on the wild-type control. B. 
Anti-keratin 5  antibody staining in epidermis of p63
-/-
 and control 
littermates. C. Deduction of p63 function in epithelial morphogenesis. The 
steps where the process of epidermal development is blocked in p63
-/-
, were 
deduced separately by Mills et al. (1999) and Yang et al. (1999) as 
commitment and proliferative potential of stem cells, respectively (Fig. A 
and B adapted from Yang et al, p63 is essential for regenerative 
proliferation in limb, craniofacial and epithelial development, Nature, 
1999) 
 
These observations suggest that p63 has a crucial role in tissue 
morphogenesis and maintenance of epithelial stem cell compartment. 
Among other defects, p63
-/-
 mice display cleft lip and palate. In wild-type 
mice, the palatal shelves first appear at around E12.5
 
and rapidly
 
grow in a 
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vertical plane flanking the developing tongue (Fig. 4).
 
 During E12.5–E13.5, 
the shelves, consisting of rapidly proliferating mesenchymal
 
cells, undergo 
elevation to bring them into horizontal
 
apposition above the tongue. 
Following
 
elevation, the medial edge epithelial (MEE) of the opposing 
palatal
 
shelves fuse in the midline through interactions of cell adhesion
 
molecules and desmosomes. The resulting epithelial seam is rapidly
 
removed through a combination of programmed cell death, epithelial
 
cell 
migration and transdifferentiation (20, 21). Palatogenesis
 
is considered to be 
complete in mouse by around E15.5 (Fig. 4). 
 
 
Figure 4. Critical stages of  palate development. Mouse palatogenesis 
starts at embryonic day (E) 11.5. By E13.5, palatal shelves (P) are on both 
sides of the tongue (T). Between E13.5 and E14.0, palatal shelves turn 
horizontally above the tongue and face each other along the midline. At 
E14.5, palatal fusion begins to take place. The arrow indicates the midline 
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epithelial seam. n, nasal epithelium; o, oral epithelium. From E15.5 to 
E16.5, palatal fusion is completed throughout the entire palate (Adapted 
from Chai, Y, Recent advances in craniofacial morphogenesis, Dev Dyn, 
2006).  
 
In p63
-/- 
mice, an abnormal morphogenesis of the medial and lateral nasal 
and maxillary processes is present at E10.5. Analysis of key signaling 
molecules revealed that these defects result from increased Bmp4 signaling 
in the epithelium of the facial processes (22). In addition, defective 
proliferation of mesenchymal cells of the maxillary processes at E11.5 
resulted in absence of the anterior region of the palatal shelves and, 
subsequently, cleft palate. Cleft lip is caused by down-regulation of the key 
signaling molecules Fibroblast growth factor 8 (Fgf8) and Sonic hedgehog 
(Shh) that led to reduced mesenchymal cell proliferation, regional growth 
defects and altered morphogenesis of the nasal processes (22). 
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1.5 p63-Associated disorders 
Heterozygous mutations in the human p63 gene cause developmental 
disorders, characterized by various combinations of ectodermal dysplasia 
(ED), limb malformations and orofacial clefting (23, 24). To date, seven 
different disorders have been linked to mutations in the p63 gene (25). 
These conditions have overlapping phenotypic features, but some genotype-
phenotype correlations have emerged (26). EEC syndrome (Ectrodactyly 
Ectodermal dysplasia and Cleft lip/palate, OMIM 604292) is the most 
common p63-linked ED. It is characterized by three major clinical 
symptoms: cleft lip and/or palate, ED (abnormal teeth, skin, hair, nails and 
sweat glands) and limb malformations in the form of split hand/foot 
(ectrodactyly) and/or fusion of fingers/toes (syndactyly). About 10% of p63-
linked patients have AEC (Ankyloblepharon Ectodermal defects Cleft 
lip/palate) syndrome (OMIM 106260). AEC syndrome is characterized by 
ED and orofacial clefting, but does not show the severe limb malformations 
seen in EEC syndrome. EEC and AEC syndromes are good examples of a 
strong genotype – phenotype association (Fig. 5). Mutations in EEC 
syndrome are clustered in the DNA binding domain, and most likely alter 
the DNA-binding properties of the protein. In contrast, mutations in AEC 
syndrome are clustered mostly in the SAM and rarely in TI domains in the 
carboxy-terminus of p63! (27, 28). The SAM domain is involved in 
protein-protein interactions, whereas the TI domain can bind intra-
molecularly to the transactivation domain, thereby inhibiting transcription 
activation (15). The other p63-associated syndromes are: Limb Mammary 
Syndrome (LMS, OMIM 603543), Acro-Dermato-Ungual-Lacrimal-Tooth 
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syndrome (ADULT, 103285) and non-syndromic Split Hand/Foot 
Malformation (SHFM4, OMIM 605289) (29). All p63-linked disorders are 
inherited in an autosomal dominant manner and mutations are thought to 
have either dominant-negative or gain-of-function effects (30).  
 
 
Figure 5. Genotype to phenotype correlation of p63 mutations. 
Mutations in EEC syndrome are clustered in the DNA binding domain 
(green) and are strongly characterized by limb malformations in the form of 
split hand/foot (ectrodactyly) and/or fusion of fingers/toes (syndactyly) (Left 
image, adapted from Celli et al, Heterozygous germline mutations in the p53 
homolog p63 are the cause of EEC syndrome, Cell, 1999); in contrast, 
mutations in AEC syndrome are clustered in SAM domain (blue)  and fulfill 
the criteria of ectodermal dysplasia and orofacial clefting (Right image, 
adapted from McGrath et al, Hay-Wells syndrome is caused by heterozygous 
missense mutations in the SAM domain of p63, Hum Mol Genet, 2001). 
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1.6 AEC syndrome 
Ankyloblepharon-Ectodermal defects Cleft lip/palate syndrome (AEC), also 
known as Hay–Wells syndrome, was first reported by Hay and Wells in 
1976 (31). Its main symptoms are ankyloblepharon (fusion of the eyelids), 
ectodermal defects and cleft lip and palate. Clinical manifestations have 
different penetrance: about 75% of patients have severe skin erosions at 
birth, with some AEC patients reported to have up to 70% denuded skin 
(32). By 4 – 5 years age erosions could disappear, except for the head and 
auricular region. Alopecia is also often linked to AEC syndrome as are 
absence of eyelashes and eyebrows. Clefting occurs approximately in 80% 
of AEC patients. The denominative ankyloblepharon occurs only in 44% of 
AEC cases. Hearing loss has been reported in about 40% of the patients. 
AEC patients have nail and teeth defects in about 75–80% of cases. About 
half of the patients have lacrimal duct atresia. One significant difference to 
the other p63 syndromes is the absence of limb malformations; only a few 
number of patients have a mild syndactyly (29). AEC syndrome is very 
similar to Rapp Hodgkin syndrome (RHS, OMIM 129400); these 
syndromes are possibly variable manifestations of the same clinical entity 
(25, 27). Although AEC and RHS syndromes have always been linked to 
the !-tail of the p63 gene, three novel mutations were recently discovered in 
the 5’ end of the p63 gene (33).  
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1.7 The Sterile alpha motif (SAM) domain 
Determining the state of protein complex formation is critical for 
understanding many signaling and structural pathways. Often protein 
interactions are mediated through conserved domains. The SAM domain is a 
commonly occurring motif, facilitating diverse interactions including 
protein homo-dimerization, hetero-dimerization, and even RNA binding 
(34, 35). Defects in the SAM domains of proteins have been observed in a 
number of human diseases (35, 36). Although in vitro SAM domains are 
capable of forming both homo- and hetero-oligomers, it remains unclear 
how SAM domains mediate protein interactions under in vivo settings, 
where most proteins are expressed at levels much lower than those often 
used in biochemical and structural analyses. It is also unknown how these 
domains might be engaged in hetero or homo-oligomer formation in vivo, in 
the presence of the full-length proteins expressed at their endogenous levels 
and in the presence of additional interacting partners. 
The full-length !-isoform of p63 and p73 contains at the C-terminal a SAM 
module, which is absent in all other isoforms. These isoforms show p53-like 
function dramatically reduced in comparison with other non-SAM-
containing isoforms, suggesting that SAM domain could be responsible for 
those functional differences (37). The SAM domain consists of a small 
(~70-amino acid) protein–protein interaction module found in a variety of 
proteins involved in developmental regulation, signal transduction and 
transcription (38). The common mechanism of interaction is homo- and 
hetero-oligomerization among similar SAM domains (39, 40). The solution 
structure of the C-terminal domain of human p63 (505-579) was solved 
through NMR spectroscopy (41). The resulting structure shows the 
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characteristic five-helix bundle topology observed in other SAM domains 
(38). It includes helix 1 (!1; residues 514–521), helix 2 (!2; residues 527–
533), a short 3
10
 helix (H3; residues 538–542), helix 4 (!4; residues 546–
551), and helix 5 (!5; residues 556–573). The five helices are tightly packed 
together via an extended hydrophobic core and form a globular and compact 
structure (Fig. 6). Possibly, the unknown interacting protein is involved
 
in 
the selection of specific p63 target genes. Such a role would
 
be in 
accordance with the specific phenotype of AEC syndrome,
 
which in contrast 
to EEC syndrome, does not include ectrodactyly,
 
but instead presents with 
ankyloblepharon and severe scalp dermatitis (28).  
Interestingly, none of the residues that
 
are involved in dimerization or 
oligomerization in crystal structures
 
of other SAM domains has been found 
to be mutated in
 
p63. This observation could suggest that the SAM domain 
of p63 is
 
capable of interaction with a non-SAM domain protein. Disruption
 
of this interaction then gives rise to the typical developmental
 
defects of 
AEC syndrome (28). 
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Figure 6. Position of missense mutations in the p63 SAM domain that 
cause AEC syndrome. (A) Multiple sequence alignment of SAM domains 
of p63 with SAM domains of other proteins. The five helices are indicated 
as H1–H5. The white helices are the helices in the Eph receptors and the 
yellow parts are the helices in p73. Identical and similar amino acids are 
depicted in white boxes. Residues that are involved in dimerization are 
highlighted in blue. The mutated amino acids in p63 are indicated with red 
boxes. (B) Homology model of the p63 SAM domain. A similar five-helical 
fold is predicted as for p73 and the other SAM domains with known 
structure. The position of mutated amino acids is indicated in red. On the 
right is a space-filling representation, showing the clustering of amino acids 
glycine 534, threonine 537 and glutamine 540 on the surface of the p63 
SAM domain. The left panel is a ribbon model turned by 90° that shows the 
position of all mutated amino acids. Amino acids leucine 514, cysteine 526 
and isoleucine 541 are buried inside the SAM domain and are likely to be 
involved in the proper packing of the helices (Adapted from McGrath et al, 
Hay-Wells syndrome is caused by heterozygous missense mutations in the 
SAM domain of p63, Hum Mol Genet, 2001). 
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2. MATERIALS AND METHODS 
 
2.1 Targeting vector 
A targeting vector for introducing a T-to-A substitution, which generated a 
phenylalanine in place of a leucine in 514 position into exon 13 of murine 
p63 gene locus, was constructed with the bacterial artificial chromosome 
(BAC) recombineering technique using the recombinogenic bacterial strain 
EL350 in accordance with procedures described by Liu Pentao (42). The 
first step consisted in subcloning DNA via gap repair from BAC bMQ-
241L2 (Sanger institute, 129S7/AB2.2 BAC clones) into a pBluescript 
vector. The mouse BAC clone bMQ-241L2 contained an insert of 152,989-
bp of genomic DNA from chromosome 16 and included a large part of p63 
gene that is about 200,000-bp. Two sets of PCR primers were produced and 
used to amplify two 500-bp regions of the BAC (NotI-p63ex12For: 
5’ATAAGCGGCCGC-CAGGATGCTGCTGGTGATAA3’ and HindIII-
p63ex12Rev: 5’GTCAAGCTT-GGAGCCACAATAGCCCTGTA3’; 
HindIII-p63-3’UTRFor 5’GTCAAGCTT-
TGCAAAAGCAAATGAGTCCT3’ and SpeI-p63-3’UTRRev: 
5’TCTACTAGT- GGAATCCCATTCTCCACTGA3’). These two regions 
marked the ends of the fragment to be subcloned via gap repair from the 
BAC into pBluescript vector. The PCR products were purified using spin 
columns and digested with either NotI and HindIII or HindIII and SpeI. 
Restriction sites for these enzymes were included in the amplification 
primers to permit directional cloning of the PCR products into pBluescript 
cut with NotI and SpeI. The vector obtained by ligation of miniarms and 
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pBluescript was subsequently linearized with HindIII to create a DNA 
double-strand break for gap repair. The linearized vector was electroporated 
into the recombinogenic bacterial strain EL350 in which previously was 
electroporated the bMQ-241L2 BAC clone. The obtained repaired vector 
contained exons 12-13-14 and the 3’UTR of p63 gene. In this vector we 
inserted the L514F point mutation and the positive selection marker PGK-
Neo in one recombineering step by electroporating in the EL350 
recombinogenic bacterial strain the repaired vector and a linearized DNA 
fragment containing the PGK-Neo cassette flanked by lox P site and by the 
regions between which the marker had to be inserted: at 5’ by a 250-bp 
region containing the L514F mutated exon 13 and at 3’ by the intron 13. 
The L514F mutated exon 13 was amplified by PCR from a vector in which 
previously was cloned and mutagenized, with following primers: 
NotI-ex13_for   5’ATAAGCGGCCGC-
CAAATCGCCAGCTGAAAAAT3’ 
EcoI-ex13_rev   5’GTCGAATTCC-GAGGTTCTGACCTGGAGAG3’ 
The intron 13 was amplified from the repaired vector with the following 
primers: 
BamHI-intron13 for  5’ATAGGATCCGCAATCAATATGCCTGATCCT3’ 
SalI-intron13 rev      5’GTCGTCGACTTTCTGCTCTCCTGCCTGAT3’ 
The PCR amplified regions, after spin columns purification, were digested 
respectively with NotI and EcoRI and BamHI and SalI and were ligated in 
the pL251 vector with the PGK-Neo cassette EcoRI-BamHI cut from this 
same vector.  The resulting minitargeting vector was NotI -SalI digested to 
obtain the PGK-Neo cassette flanked by the two regions of homology and 
electroporated in EL350 E.Coli bacterial strain together with the repaired 
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vector containing the p63 sequence. The final vector containing a PGK-neo 
cassette flanked by lox P sites and the L514F point mutation in the exon 13 
was electroporated in mouse E14Tg2A embryonic stem (ES) cells.  
 
 
2.2 Growing E14Tg2A ES cells 
E14Tg2A (BayGenomics) is a feeder indipendent ES cell line derived from 
the 129/Ola mice strain. The cells were cultured on  0.1% of gelatin (Sigma) 
in ES cell medium containing leukocyte inhibitory factor (Chemicon catalog 
# ESG1107). ES cells were routinely passaged every 2 days and the medium 
was changed every day.  
 
 
2.3 Gene Targeting in Embryonic Stem (ES) Cells and Generation of 
p63
+/L514F
 mice 
About 3 x 10
7
 ES cells were resuspended in 750µl PBS and placed in 0.4 cm 
cuvettes;  15-25µg of targeting vector linearized with NotI restriction 
enzyme, were added to the cells and introduced in ES cells by 
electroporation (250V 500µF) in a Bio-rad gene pulser. After 
electroporation cells were plated in 6-8 p100 dishes. After 24 hr, the cells 
were placed under selection with 100 µg/ml G418 (GIBCO/BRL) for 7 
days. Four hundred neomycin-resistant positive ES clones were screened at 
3’ and 5’ of the insertion in the p63 endogenous locus by PCR analysis 
using an oligo that anneal in the neomycin cassette and an oligo in the 
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genomic DNA.  Screening to 5’ of the insertion was performed with the 
following primers: 
EsScreen5'F   5’ CAGACTGCAGCATTGTCAGGTGAG 3’ 
EsScreen5'R   5’ GCTAGCTTGGCTGGACGTAAACTC 3’ 
Screening to 3’ of the insertion was performed with the following primers: 
EsScreen3'F ATGGCTTCTGAGGCGGAAAGAACCAG 
EsScreen3'R AGGCCAGAGGTCAGAAGGATGAACACAC 
Only one clone was positive to both 3’ and 5’ PCR analysis. The 
homologous recombination event was confirmed by southern blotting. 
Genomic DNA, purified from wild-type or putative recombinant ES cells, 
was digested with EcoRI and analyzed with a probe located upstream of the 
recombinant targeted site. The wild-type allele resulted in a band of 5392-
bp. The recombinant ES clone contained the wild-type band as well as a 
recombinant band of 3216bp, consistently with the homologous 
recombination event. We also performed southern blotting analysis with a 
probe that anneal the neomycin coding region, to verify that not more of one 
copy was inserted in the p63 endogenous locus. The presence of mutation in 
the endogenous locus was confirmed by the sequencing of genomic DNA. 
The positive clone was injected into blastocyst embryos that were implanted 
into pseudopregnant female. We obtained six chimeras in a first injection 
procedure and ten chimeras in a second injection procedure with different 
fur coat colours. The chimeras were all tested for germline transmittability 
by breeding with B6D2F1 mouse strain. To distinguish between wild type 
and mutant mice, newborn mice were screened for cleft palate (the 
phenotype is lethal) and by the PCR genotyping. 
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2.4 Southern blotting analysis 
Subconfluent adherent cells were washed 2X with PBS and 2ml/100mm of 
DNA lysis buffer were added (100mM NaCl, 50mM Tris-HCl, pH8, 
100mM EDTA, pH8, 1%SDS, 1mg/ml Proteinase K). Cells were incubate 
2-3 hours in culture dish at 55°C. 
Genomic DNA was extracted with phenol (pH 8.0) 2X. DNA samples were 
shaken for some minutes in order to avoid a long contact of DNA with 
phenol and spinned in Sorvall 10' at 10000 rpm; after chloroform extraction 
2X (same procedure as for phenol), DNA was washed in 70% ethanol, dried 
and resuspended in 1ml TE by rotating sample few hours at r.t. About 14 !g 
of DNA were digested in a total volume of 150!l with !5U/!g of  EcoRI (or 
BglII, HindIII, EcoRV in the case of  southern blotting with the probe that 
anneal on neomycin cassette ) enzyme o/n. Following a first Phenol/ 
Chloroform extraction, purified DNA was digested again in a total volume 
of 100!l with !5U/!g of appropriate enzyme for ~4-5 hours. After a second 
Phenol/ Chloroform extraction, DNA samples were washed, dried for max. 
10 minutes; 15!l of H2O were added and DNA was resuspended at 65°C for 
10-15 minutes. Samples were loaded on 0.7% agarose gel and run at ~35mA 
o/n. The day after the agarose gel was placed in a tray with 250-500ml of 
HCl solution (21.6ml HCl/1 liter ddH2O)  and incubated 2 X 15' at r.t. to 
nick DNA and facilitate the transfer of DNA bands on nylon membrane.  
Then the gel was rinsed 2X with ddH2O and soaked 20-30' 2X in a fresh 
denaturating solution (1.5M NaCl, 0.5M NaOH). Finally agarose gel was 
soaked  20-30' 2X in neutralization solution (1M Tris pH7.2, 3M NaCl ).   
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DNA bands were transferred from the agarose gel to a nylon membrane by 
placing the membrane on top of gel and filling the blotting tray with 20X 
SSC. After 24 hours the blotting pads were stacked and the nylon membrane 
was UV crosslinked in Stratalinker (stratagene). The membrane was 
prehybridized with 43% Formamide 5X, SSC 0,2%, SDS 50 mM, 
Phosphate buffer pH 7.0, 5X Denhardt solution, 400 !g/ml yeast tRNA, 50 
!g/ml Salmon sperm o/n. Then the membrane was incubated o/n with the 
radiolabeled probe prepared using Amersham rediprime kit for random 
prime labeling. The day after the membrane was washed twice, 10 minutes 
each, with a low stringency wash (2x SSC, 0.1% (w/v) SDS), then with a 
medium stringency wash (lx SSC, 0.1% (w/v) SDS) for 15 minutes and 
finally twice, 10 minutes each, with a high stringency wash (0.lx SSC, 0.1% 
(w/v) SDS). The membrane was exposed to X-ray film for 24-48 hours. 
 
 
2.5 Mouse genotyping 
p63
+/L514F
 mutant mice are  genotyped by PCR using genomic DNA isolated 
from mouse tails. Primers used for amplification of wild-type allele were:  
Screen-ex13L514F-For 5’-GTCTGACCTCCCGACCCACCTCCT-3’  
Screen-ex13L514-wild-type-Rev 5’-
GCATGATGAGCAGCCCAACCTTGCT-3’ 
Primers used for amplification of mutant allele were:  
Screen-ex13L514F-For 5’-GTCTGACCTCCCGACCCACCTCCT-3’  
Screen-ex13L514F-Mut-Rev 5’- 
GCATGATGAGCAGCCCAACCTTGCA-3’ 
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Forward primer was in common while the reverse primer differed only at 3’ 
for the presence of the point mutation. Genomic DNA from p63
+/L514F
 was 
amplified by both couples of primers, whereas genomic DNA from wild-
type littermates was amplified only by the oligo reverse with the correct 
base in 3’ first position. 
 
 
2.6 Histopathology and Immunostaining 
Dorsal skin were dissected, fixed in 4% paraformaldehyde (PFA) and 
embedded in paraffin or in OCT, from which 7 µm sections were cut and 
stained with Haematoxylin and Eosin (H&E) or by immunohistochemistry 
according to standard methods. For paraffin sections, permeabilization for 
antigen retrieval was performed by microwaving samples in 0.01 M citrate 
buffer at pH 6.0. The following antibodies were used: rabbit antibodies to 
keratin 6, keratin 14, keratin 1, involucrin, loricrin (all Convance), Caspase 
3 active (R&D system), mouse antibodies to BrdU G3G4 (originally 
provided by Dr. Steve J. Kaufman, Illinois and maintained by the 
Developmental Studies Hybridoma Library, University of Iowa), p63 (4A4, 
Santa Cruz Biotechnology), alpha tubulin (Sigma), rat antibody to E-
cadherin (Zymed laboratories-Invitrogen), goat antibody to IGF2 (R&D 
system), guinea pig antibody to keratin 15 ( a gift from Langbein). The 
following secondary antibodies were used for immunofluorescence staining: 
Alexa Fluor ® 488 goat anti-mouse (Invitrogen), Alexa Fluor ® 594 goat 
anti-rabbit (Invitrogen), Alexa Fluor ® 594 goat anti-rat (Invitrogen). 
Fluorescent signals were monitored under a Zeiss Axioskop2 plus image 
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microscope or under a Zeiss confocal microscope LSM510meta. 
 
 
2.7 Western Blot  
For immunoblotting cells were lysed in sample buffer (10% glycerol, 0.01 
% Bromophenol Blue, 0.0625 M Tris-HCl pH 6.8, 3 % SDS, 5 % ß-
mercaptoethanol) supplemented with protease inhibitors. For 
immunoblotting of epidermal extracts, epidermis was isolated from dermis 
by producing a termic shock at 55°C or by floating skin biopsies, epidermis 
side up, in a 0.5 M ammonium thiocyanate (NH4SCN) in phosphate buffer, 
pH 6.8 (0.1 M Na2HPO4, 0.1 M KH2PO4) for 20 min on ice. After isolation 
from dermis, epidermis was snap frozen in liquid nitrogen and then 
homogenized with a polytron in lysis buffer supplemented with phosphatase 
and protease inhibitors. Twenty-five micrograms of protein per lane were 
run on a denaturing SDS-PAGE gel and subsequently transferred to 
Immobilon-P transfer membranes (Millipore) probed with primary 
antibodies and detected by chemiluminescence (ECL, GE Healthcare Life 
Sciences). Antibodies used for immunoblotting were rabbit anti-total-AKT, 
rabbit-phospho-AKT
Ser
, rabbit anti-phospho-p44/42 MAPK and rabbit anti-
total-p44/42 MAPK (1:1,000; Cell Signaling Technologies) and those listed 
above. Secondary antibodies included donkey anti-rabbit IgG and sheep 
anti-mouse IgG conjugated to horseradish peroxidase (HRP) (1:2000; 
Amersham Biosciences), as well as donkey anti-goat HRP and goat anti-rat 
HRP (1:1000; Santa Cruz Biotechnology). To detect multiple proteins, 
membranes were treated in stripping buffer (100 mM b-mercaptoethanol, 
Materials and Methods 
  
25 
2% SDS, and 62.5 mM Tris [pH 6.8]) and then reprobed.  
 
 
2.8 BrdU incorporation assay 
Cells were labeled with 5-bromo-2-deoxyuridine (BrdU, Zymed, 1:100) for 
3 hrs, and then fixed in 4% PFA, washed in phosphate-buffered saline 
(PBS), treated with 50mM NaOH, and permeabilized in 0.1% NP-40. Cells 
were subsequently incubated with anti-BrdU antibody listed above (1:500) 
in the presence of DNAse (0.2 mg/ml, Sigma) and detected by 
immunofluorescence using Alexa Fluor ® 488 goat anti-mouse (Invitrogen). 
For in vivo analysis, BrdU was injected (1ml/100g body weight) 
intraperitoneally in pregnant mouse females and incubated for 3hrs. 
Embryos were taken at E13.5, E16.5 and P0 stages, fixed in 4% PFA, and 
embedded in paraffin. 7!m sections were permeabilized in 0.2% Triton X-
100, and processed for immunofluorescence as described above. 
 
 
2.9 Skin Barrier Assays 
 To perform X-gal staining, unfixed, untreated newborn mice or embryos 
were washed in PBS and then incubated overnight at 37°C in 5-bromo-4-
chloro-3-indlyl-b-D-galactopyranoside (X-gal) reaction mix (100 mM 
NaPO4, 1.3 mM MgCl2, 3 mM K3Fe[CN]6, 3 mM K4Fe[CN]6, and 1 mg/ml 
X-gal [pH 4.5]). At pH 4.5, the skin exhibits endogenous b-galactosidase 
activity, so increased X-gal staining indicates epidermal permeability to X-
gal, a sign of compromised barrier function (43). 
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2.10 Primary keratinocytes 
Newborn mice were placed in petri dishes with ice and inserted in an ice 
bucket.  After 30-45’ newborn mice were washed twice with 70% ethanol 
and twice with water to remove ethanol completely. Using sterile 
techniques, mice tails and limbs were amputated with sterile surgical 
scissors. The skin was carefully separated from the rest of the viscera and 
flattened in a empty 150mm petri dish with the dermis facing down; 20 ml 
of Dispase solution (Roche) were added  to each petri dish and incubated 
o/n at 4 °C. Next day epidermis was separated from the dermis and placed 
in a 100mm Petri dish in 2,5ml (for each epidermis) of  0.125% trypsin- 
2.5mM EDTA. Epidermis was minced with tweezers and scissors until is 
reduced in very small fragments and placed at 37°C for 5-8 minutes. Then 
trypsin is inactivated with DMEM+10% FBS and filtered by applying it to a 
gauze in order to remove the floating particles. Cells were placed into the 
centrifuge for 5 minutes at 1000 rpm; then were plated on collagen coated 
plates (2x10
6
 cells/ml) and incubated at 34°C, 8% CO2.  
 
 
2.11 Colony-forming assays 
About 10
3
cells/cm
2
 were plated on 35mm dishes coated with 2mg/35mm 
dish of Matrigel (BD Bioscience) in Defined PCT-Epidermal keratinocytes 
medium (CellnTec advanced cell system); keratinocytes were cultured for 
three weeks. Then cells were washed in PBS and stained with Crystal violet 
for 10 minutes.  
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2.12 Real-time RT-PCR 
Total RNA was extracted from primary keratinocytes or epidermis (isolated 
from the dermis with the method described above) using TRIzol reagent 
(Invitrogen). RNA samples were treated with RNase-free DNase I 
(Promega), and cDNA was synthesized using SuperScript Vilo (Invitrogen). 
Two-step real-time reverse transcription RT-PCR was performed using the 
SYBR Green PCR master mix in an ABI PRISM 7500 (Applied 
Biosystems). Levels of the target genes were quantified using specific 
oligonucleotide primers and normalized for Actb (ß-actin) expression. 
  
 
2.13 Fluorescent activated cell sorting (FACS) analysis  
Keratinocytes were isolated from newborn mice with the procedures 
described (see paragraph “Primary keratinocytes”) and stained for one hour 
with both CD49f and CD71 primary antibodies (BD Bioscience). For each 
sample at least 10000 events were acquired with FACSCanto II Flow 
Cytometry System (BD Biosciences), and analyzed with the ModFit LT 3.0 
software (Verity Software House). 
 
 
2.14 Gene expression microarrays 
We measured the differential expression of  22000 RNA on freshly isolated 
epidermis from three mutant versus three wild-type newborn mice. We 
hybridized the RNA samples to the Affymetrix Mouse Genome 430A 2.0 
chips. We processed the microarrays using the RMA algorithm. False 
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Discovery Rate (FDR) correction was perfomed on the estimated p-value to 
correct for multiple hypothesis test.  
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3. RESULTS 
 
3.1   Generation of a mouse model carrying the L514F AEC human 
mutation 
We generated a knock-in mouse model for AEC syndrome by inserting the 
L514F point mutation, that has been found in a number of AEC patients 
(28), in an otherwise wild-type p63 gene. The targeting vector was created 
through BAC recombineering using the recombinogenic bacterial strain 
EL350 (42). 
This vector contains the L514F point mutation in the exon 13 that encodes 
for the SAM domain (see Introduction) and the positive selection marker 
PGK-Neo flanked by lox-P sites for Cre!recombinase mediated removal. 
The mutation was introduced by homologous recombination (knock-in 
strategy) in the p63 gene locus of mouse embryonic stem (ES) cells 
E14Tg2A (BayGenomics), a feeder indipendent ES cell line derived from 
the 129/Ola mice strain (Fig. 7A).  
We extensively validated the homologous recombination event by PCR and 
Southern blotting. The genome of the ES positive clone was sequenced to 
confirm the presence of mutation (Fig. 7B). Then, blastocysts injected with 
mutant ES cells, were transferred into pseudopregnant C57BL/6 female. We 
obtained six chimeras in a first injection procedure and ten chimeras in a 
second injection procedure. After we have tested their transmittability, 
chimeric mice carrying the L514F AEC mutation were mated with wild-
type B6D2F1 mice to obtain p63
+/L514F 
heterozygous mice.  
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Figure 7. Generation of the p63
+/L514F
 knock!in mouse model. A. The 
L514F human mutation (*) was inserted in exon 13 of the p63 gene, that 
encodes the SAM domain. A PGK!neo positive selection cassette, flanked 
by loxP site, was placed downstream of exon 13. B. Left panel: Genomic 
DNA, purified from wild-type (wild-type) or L514F ES cells were digested 
with EcoRI and analyzed with a probe located upstream of the recombinant 
targeted site. The wild-type allele results in a band of 5392bp. The L514F 
ES clone contained the wild-type band as well as a recombinant band (Rec) 
of 3216bp, consistently with the homologous recombination event. The 
mutation was confirmed by sequencing genomic DNA. Right panel: The 
L514F mutation in the p63
+/L514F
 mouse DNA was detected by PCR analysis 
using primers for either the mutated or the wild-type sequence. 
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3.2 p63
+/L514F
 mice recapitulate  the phenotype of AEC patients 
p63
+/L514F
 mice died within 12 hours after birth; the cause of death is the 
severe cleft of the secondary palate that results in stomach and intestine 
filled with swallowed air and complete absence of milk in the stomach (Fig. 
8A-B). Facial processing fused properly at early stages of development so 
that mice were not affected by cleft lip (Fig. 8A).  
During development in p63
+/L514F
 mice the palate shelves elevated, but do 
not came in close proximity to fuse and form the secondary palate. In 
humans this defect is compatible with life and can be treated surgically. 
p63
+/L514F
 mice showed skin defects, ectodermal dysplasia, including defects 
in tooth and hair development, epidermal and hair follicle hypoplasia and no 
limb abnormalities, thus faithfully recapitulating the defects observed in 
AEC patients.  
 
 
Figure 8. Cleft palate of p63
+/L514F
 mice. A.  Clefting affected the hard 
palate (secondary palate) as indicated by the black arrow. B cleft palate was 
responsible for dehydration since mice were unable to take milk and for 
bubble in the stomach (white arrow) due to inability to breathe. 
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We performed a BrdU incorporation analysis on two p63
+/L514F
 versus two 
wild-type mice at E13.5 and we found that proliferation of mesenchymal 
and epithelial cells was not affected by the mutation (Fig.9A). Thus, our 
preliminary result indicated that elevation and reorientation of palatal 
shelves at E13.5 occurred properly. A larger number of mutant and wt mice 
will be necessary to analyze in order to confirm this result.  
Haematoxylin and Eosin (H&E) staining on palatal section of p63
+/L514F
 and 
wild-type mice at E14.5 and E15.5 showed that the defect is detectable at 
E14.5 because the opposing palatal shelves fail to meet in the horizontal 
plane; it persist at E15.5, whenthe palatogenesis was complete in wild-type 
mice, and after birth (Fig. 9B 
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Figure 9. Mutant palatal shelves do not come in contact. A. BrdU 
incorporation analysis on E13.5 p63
+/L514F
 versus wild-type embryos 
showed correct proliferation of mesenchymal and epithelial cells of palatal 
shelves. Charts below: quantification of the percentage of BrdU positive 
mesenchymal and epithilial cells B. H&E staining showed that palatal 
shelves fail to meet in the horizontal plane at E14.5; the defect persists at 
E15.5 (black arrow) and until the birth.  
 
We mainly focused our attention on skin phenotype. We performed H&E 
staining on several skin sections isolated from the of  p63
+/L514F
 and wild-
type mice and we found an overall reduction in skin thickness, accompanied 
by a significant epidermal and hair follicle hypoplasia with a penetrance of 
100% (Figure 10A). 
The vast majority of p63
+/L514F 
mice did not display skin erosions at birth, 
but their epidermis was fragile and easily broke above the basal layer during 
histological processing (Figure 10B).  
We measured the epidermal thickness from the basal lamina to the granular 
layer. Measurement was performed on six p63
+/L514F 
versus wild-type skin 
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sections of newborn mice stained with H&E. We found a highly significant 
reduction in epidermal thickness of about 50% (Fig. 10C). 
 
 
 
 
Figure 10. Skin hypoplasia and fragility in p63
+/L514F
 mice. A. H&E 
staining of skin sections at birth; Black arrows indicate the epidermal 
thickness of mutant versus wild-type skin. B. Focal epidermal gaps between 
the basal and the spinous layers of the epidermis (black arrow). C. 
Measurements of epidermal thickness in wild-type and p63
+/L514F
 skin at 
birth. * indicates a statistically significant difference (p!value=0.0009 
(n=6)).  
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Epidermal alteration in our mouse model was confirmed by the ectopic 
expression of Keratin 6 (Krt6). We found a variable increase in protein 
production by immunoblotting analysis performed on epidermal extract of 
wild-type and p63
+/L514F
 newborn mice skin (Fig.11A) and an induction of 
Krt6 in the differentiating layers of p63
+/L514F
 mice by immunofluorescence 
staining (Fig. 11B). Under physiological condition Krt6 is expressed in the 
companion layer, matrix, and medulla of anagen-stage hair follicles, but not 
in epidermis (44, 45). Injury to stratified epithelia causes a strong induction 
of Krt6 in post-mitotic keratinocytes located at the wound edge. The 
induction occurs within 6 h after injury to human epidermis. Its subsequent 
accumulation in keratinocytes correlates with the profound reorganization of 
keratin filaments in suprabasal keratinocytes, followed by alteration in their 
shape and cell-cell adhesion. These changes coincide with the onset of re-
epithelization (46). Although p63
+/L514F 
mice did not display detectable 
lesions we found an increase in Krt6, consistent with the possibility that 
p63
+/L514F 
mice die before the skin fragility phenotype evolves in detectable 
lesions.  
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Figure 11.  Expression of Krt6 on epidermis of  wild-type and p63
+/L514F
 
newborn mice. A. Immunofluorescence staining with an antibody against 
Krt6 showed an aberrant expression in the differentiating layers of mutant 
epidermis. B. Immunoblotting of epidermal extracts with Krt6 showed an 
increased production of this protein in mutant mice; !-TUBULIN (!TUB) 
was used to normalize samples. 
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3.3  Global gene expression profile of  p63
+/L514F
 
To obtain a global view of changes in gene expression of p63
+/L514F
 mice, 
we performed a comparison of gene expression profiling of mutant versus 
wild-type epidermis at birth using Affymetrix gene chip. We found 63 
downregulated and 23 upregulated transcripts in AEC mutant epidermis 
versus wild!type (FDR<0.2, 2 fold induction). Six genes are putative direct 
targets of p63 as suggested by previous ChiP-chip experiment (47, 48). 
Interestingly, a number of bona-fide direct p63 target genes, including Perp 
(49), Keratin14 (Krt14) (50), and Redd1 (51), were unaffected in mutant 
epidermis, and only a limited number of genes were differentially expressed 
in p63
+/L514F
 versus wild!type epidermis, the vast majority of which were 
also affected by p63 knockdown in keratinocytes. These data indicated that 
defects in p63
+/L514F
 mice involve likely as!yet poorly explored cellular 
mechanisms downstream of a specific subset of p63 target genes. The basal 
layer keratins Krt14 and Keratin 5 (Krt5), and the main suprabasal keratins 
Krt1 and Krt10 whose expression was lost in p63
-/-
 mice, were essentially 
unaffected in p63
+/L514F
 mice at least at birth. In contrast, mRNA expression 
of a number of other keratins typical of the epidermis was inhibited at birth, 
including Keratin 15 (Krt15), Keratin2 (Krt2) and the poorly characterized 
Keratin 79 (Krt79). Interestingly Krt79 in humans is highly expressed in the 
scalp (52), the main site of skin erosions in AEC patients. In parallel with 
reduced expression of some epidermal keratins, p63
+/L514F
 epidermis 
displayed increased focal expression of other keratins, including Krt6 
(Fig.11) and Keratin 16 (Krt16) that are essential to maintain keratinocyte 
integrity in wounded epidermis (45), and Keratin 8 (Krt8) and Keratin 18 
(Krt18), simple epithelial keratins, that for their nature can participate to 
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intermediate filaments but do not confer strong mechanical resistance to the 
epithelium (data not shown). Interestingly, Krt15 was strongly reduced at 
the protein level both in the epidermis and in the bulge of hair follicle at 
birth (Fig.18B), whereas Krt6 was aberrantly expressed in p63
+/L514F
 
epidermis (Fig.11A-B).  
 
 
Figure 12. Global gene expression profile of p63
+/L514F
. Comparison of 
gene expression profiling of newborn  p63
+/L514F
 versus wild!type 
epidermis using Affymetrix gene chips. 85 transcripts (2-fold; FDR<0.2) are 
significantly altered in mutant epidermis. Most bona!fide direct p63 target 
genes are unaffected in mutant epidermis.  
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3.4  Epidermal proliferation and differentiation are not affected in 
p63
+/L514F
 mice
 
During embryonic development several alterations can be responsible for 
skin fragility in p63
+/L514F
 mice since p63 has been involved in different 
biological processes including maintenance of cell proliferation (53, 54), 
induction of stratification and inhibition of terminal differentiation (55, 56). 
We tested whether these functions were affected in p63
+/L514F
 mutant skin. 
We measured epidermal cell proliferation by performing a quantitative 
BrdU incorporation assay on p63
+/L514F
 versus wt mice at birth and during 
skin maturation (E13.5, E16.5, and P0) (Fig.13A). Quantification of BrdU 
positive epidermal cells showed that the proliferation rate of mutant 
epidermal cells was comparable to that of wild-type. We obtained the same 
results by performing BrdU incorporation assay on cultured primary 
keratinocytes isolated from either p63
+/L514F
 or wild-type epidermis (Fig. 
13B). 
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Figure 13. Cell proliferation is unaffected in p63
+/L514F
 skin. A. Left: 
immunofluorescence staining of skin in newborn mice (P0), at E13.5 and 
E16.5 with BrdU (in red) specific antibody. Left: Quantification of BrdU 
positive epidermal cells B. Right: BrdU staining on keratinocytes isolated 
from wild-type and p63
+/L514F
 epidermis. Left: Quantification of BrdU 
positive keratinocytes. 
B 
A 
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To determine if epidermal differentiation was affected by L514F AEC 
mutation, we performed immunoblotting analysis on epidermal extracts 
from either wild-type or p63
+/L514F
 mice with E!cadherin (Cdh1), a 
component of the aderent junction; Keratin 14 (Krt14), a marker of the basal 
layer; Keratin 1 (Krt1), a marker of the spynous layer and Involucrin (Ivl) 
and Loricrin (Lor), markers of terminal differentiation and we did not find 
any obvious differences between wild-type and p63
+/L514F
 protein levels 
(Fig.14A). Immunofluorescence analysis on either wild-type or p63
+/L514F
 
epidermis showed that all markers localize properly (Fig.14B). Accordingly, 
the epidermal barrier was not significantly altered at E17.5 as indicated by 
permeability assay performed on wild-type and mutant embryos (Fig. 14C). 
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Figure 14. Epidermal differentiation of p63
+/L514F
 mice. A.  
Immunoblotting analysis of several differentiation markers on epidermal 
extracts collected at birth from three wild-type and three p63
+/L514F
 mutant 
mice. Krt14: Keratin 14. Krt1: Keratin 1. Ivl: involucrin. Lor: Loricrin. 
Cdh1: E!cadherin; !TUB is used to normalize samples. B. 
Immunofluorescence staining on skin section of newborn mice with Krt14, 
Krt1, Cdh1, shows a correct localization of these markers in epidermis. C. 
Permeability assay using X-gal substrate on wild-type  and p63
+/L514F
 mice 
at   E17.5 shows a complete skin barrier formation. Wild-type control 
embryos have an incomplete barrier at E16.5. 
 
 
We also evaluated differentiation at E16.5 since a delay during development 
could be responsible for incomplete stratification at birth. H&E staining on 
skin section from E16.5 p63
+/L514F 
and
 
 wild-type mice showed skin 
hypoplasia (Fig.15A). Immunofluorescence staining showed the proper 
expression and localization of Cdh1, a component of the aderent junction 
 
C 
C 
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and Krt10, a marker of the spinous layer. Thus, epidermal differentiation of 
p63
+/L514F
 mice was unaffected. 
 
 
 
Figure 15: Phenotype of p63+/L514F at E16.5. A. H&E staining of skin 
sections at E16.5. Note the reduction of skin and epidermal thickness in 
p63
+/L514F
. In spite of this reduction, immunofluorescence analysis displayed 
a correct expression and localization of epidermal markers. B. 
Immunofluorescence staining of p63
+/L514F
 mice skin sections at E16.5 with 
Krt10, a marker of the spinous layer, indicates that differentiation occurred 
correctly. 
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3.5 Defective proliferative potential of epidermal stem cells in AEC 
syndrome 
Epidermal stem cells are not localized in a specific niche but are 
interspersed with transit amplifying cells in the basal layer (see 
Introduction). Wild-type epidermal stem cells are thought to give rise to 
both transit-amplifying (TA) cells and stem cells at each cell division, which 
contributes to the logarithmic expansion of epithelial tissues. In contrast, the 
absence of p63 leads to a decrease of proliferative potential of epithelial 
stem cells (57). To investigate the effect of L514F on this p63 function we 
performed colony forming assay, FACS analysis and immunodetection of  a 
putative skin stem cell marker. 
 
 
3.5.1 Colony-forming assay 
To analyze self-renewal ability of  p63
+/L514F
 epidermal stem cells, we 
cultured for three weeks mutant versus wild-type keratinocytes in a medium 
that favors the growth of epidermal stem cells and subsequently we stained 
colonies with crystal violet (Fig.16A). Clones were divided in three 
populations on the basis of their size. We found that clones larger than two 
millimeters were only the five percent of mutant versus about the thirty-five 
percent of wild-type clones (Fig.16B). We repeated this assay three times 
and the result was consistent with a decrease in number and size of 
p63
+/L514F
 versus wild-type epidermal clones. One week after the beginning 
of the experiment, p63
+/L514F
 clones showed a different morphology 
compared to wild-type as indicated by microscopic images (Fig.16C). We 
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are investigating if this morphology is attributable to a premature apoptosis 
or senescence of keratinocytes or to an accelerated terminal differentiation.  
 
 
 
Figure 16. Colony-forming assay. A. Colony-forming assay on primary 
keratinocytes isolated from wild-type and p63
+/L514F
 mutant newborn mice 
and plated at clonal density for three weeks  in a medium that favours  
growth of epidermal stem cells. B. Quantification of the colony-forming 
assays shown in (A). C. Microscope images of wild-type and p63
+/L514F
 
keratinocytes at 7 days after plating.  
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3.5.2  FACS analysis to define epidermal stem cell population 
To test whether epidermal progenitor cells derived from p63
+/L514F
 mice 
have a reduced proliferative potential, we determined the properties of 
freshly dissociated basal keratinocytes of mutant versus wild-type epidermis 
by FACS analysis, which allowed us to distinguish putative stem cells and 
measure their physical characteristics and their cell cycle status. As 
mentioned in the introduction, epidermal stem cells have not been clearly 
identified; however, integrin !6 (CD49f) and transferring receptor (CD71) 
are used as epidermal stem cell markers (7). A number of reports suggest 
that the cell fraction characterized by high level of CD49f and low level of 
transferring receptor CD71 is enriched for cells with characteristics of 
progenitors (58, 59). 
Freshly isolated epidermal cells derived from newborn p63
+/L514F
 mice and 
their wild-type counterparts were used in this assay. We determined the 
number of putative stem cells, their physical properties including size and 
nuclear-to-cytoplasmic ratio, and their cell cycle status, as compared to the 
total population of basal cells (CD49f
medium
/
high cells
). Keratinocytes gated as 
CD49f
bri
/CD71
dim
 correspond to a cell population with the smallest cell and 
nuclear size and exhibited a high nuclear!to!cytoplasmic ratio consistent 
with the characteristics of a primitive cell type. We found that keratinocytes 
isolated from p63
+/L514F
 mice were strongly defective in this cell population 
without any changes of cell cycle parameters (Fig. 17A-B).  
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Figure 17. Epidermal stem cells from epidermis of newborn mice. A. 
Cells freshly harvested from epidermis of wild-type and p63
+/L514F
 mice 
were subsetted on the basis of CD49f (c, x axis) and CD71 (c, y axis) 
surface phenotype into fractions enriched for Stem cells (orange) and TA 
cells (blue). In the panel differentiated cells (pink) are also displayed. B. 
Percentage of stem cells in the epidermis of five different p63
+/L514F
 and 
wild-type mice. * indicates a statistically significant difference (p-
value=0.001 (n=5)). 
 
 
3.5.3 Expression of the skin stem cell marker Krt15 
Krt15 is a protein with a poorly understood role in epidermis. It is a marker 
of the proliferative compartment of epidermis (60, 61). Flow cytometric 
analysis revealed preferential expression of this keratin in CD49f
bri
 cells 
(60). In addition, patterns of Krt15 expression and promoter activity change 
with age and correlate with levels of differentiation within the cutaneous 
epithelium. In newborn mice Krt15 is expressed in the basal compartment of 
epidermis, whereas its expression becames restricted to the bulge area in the 
adult mice (62).  
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Real time PCR analysis performed on RNA extracted from epidermis of 
p63
+/L514F
 newborn mice and in their wild-type counterpart showed a 
decrease in Krt15 expression (Fig.18A). This decrease was confirmed also 
at protein level as showed by immunoblotting and immunofluorescence 
analysis (Fig.18B). 
Real time PCR analysis performed on RNA extracted from several AEC 
patients with different mutations showed a strong decrease of Krt15 mRNA 
expression (Fig.19A). Immunofluorescence analysis for Krt15, performed 
on other AEC patients, confirmed the reduction at protein level (Fig.19B).  
 
 
Figure 18. Krt15 is reduced in p63
+/L514F
 newborn skin at both mRNA 
and protein levels. A. Real time  PCR analysis on mRNA from different 
wild type (WT) and p63
+/L514F
 mice (AEC). B. Immunofluorescence 
staining for Krt15 on backskin section of wt and p63
+/L514F
 mice. 
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Figure 19. Krt15 is expressed at low levels in AEC patients. A Real time 
PCR analisys on mRNA from  several AEC patients compared to several 
human controls (CTR). B.  Immunofluorescence staining for krt15 in skin 
section of two different AEC patients compared to two human controls 
(CTR). 
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3.6 Skin hypoplasia is caused by increased apoptosis of  basal  cell 
compartment  
p63 has been involved in apoptosis with variable outcomes depending on 
the p63 isoform taken into consideration (63-66). We evaluated if an 
increase in apoptosis could account for the hypoplastic phenotype of 
p63
+/L514F
 mice. We found a significant difference in the epidermis of 
p63
+/L514F 
versus wild-type mice at P0 stage (Fig.20). Staining for active 
caspase 3 was localized in the basal layer of mutant epidermis in which are 
putatively interspersed epidermal stem cells (Fig.20). This finding could 
account for the morphology of mutant colonies in the colony-assay 
(Fig.16C). 
 
 
 
 
Figure 20. Caspase 3 is increased in the epidermis of p63+/L514F mice. 
Immunofluorescence staining on p63
+/L514F
 versus wild-type back-skin  
section from  mice at P0 stage with active caspase 3 antibody. Some basal 
cells in p63
+/L514F
 epidermis are positive to active caspase 3 (white arrows).  
Below: quantification of caspase 3 positive cells for field (Original 
magnification 20X). 
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3.7    Loss or gain of function? Analysis of mutation in p63
-/L514F
 mice 
Mice with only one copy of p63 (p63
+/-
) are indistinguishable from wild-
type littermates because one copy is sufficient to maintain the ectodermal 
development in mice. The L514F missense mutation falls in the first !-helix 
of SAM domain and causes an autosomal dominant phenotype. To uncover 
if the effect of mutation is produced by a gain of function or by a dominant 
negative effect of the mutant isoform on the p63 tetramer, we mated 
chimeras carrying L514F mutant cells in their germ line with p63
+/- 
mice to 
obtain p63
-/L514F
 mice so that we could unmask the effect of the mutation on 
a p63 background in which only p63 isoforms that do not posses SAM 
domain are expressed (p63 " and #) in single copy.  p63-/L514F were born 
with cleft palate, craniofacial abnormalities and limb defects (Fig.21A). 
These abnormalities were more severe in p63
-/- 
mice. We found that the 
epidermal phenotype of p63
-/L514F
 mice was very similar to that of p63
-/- 
mice (Fig.21B). The marker of basal layer Krt14 was expressed at E18.5 in 
both models in a discontinue monolayer often detached from derma; the 
spinous, the granular and the corneous layers were absent in both models as 
showed by immunofluorescence staining with markers of stratified layers 
(data not shown). Thus, we showed that stratification did not occur in either  
p63
-/L514F 
or p63
-/- 
mice. This finding indicates that L514F mutation affects 
primarily epidermal development, and to a lesser extent limb and 
craniofacial development. Thus, an intact ! isoform is essential for 
epidermal development, whereas # and " isoforms can at least in part rescue 
limb and craniofacial defects. 
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Figure 21. Comparison between p63
-/L514F
 and p63
-/-
 mice. A. Sagittal 
views of E18.5 control, p63
-/-
 and  p63
-/L514F
 embryos. Both models have no 
eyelids, whisker pads, skin and related appendages, which are present on the 
wild-type control. p63
-/-
 embryos have more hypoplastic upper and lower 
jaws compared to p63
-/L514F
 embryos. p63
-/-
 embryos lacks distal 
components of the forelimb and all component of hindlimbs while in the 
p63
-/L514F
 embryos the defect is milder. B. Immunofluorescence staining of 
Krt14 and Chd1 show a discontinue monolayer often detached from the 
dermis. 
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3.8 Molecular pathways involved in the pathogenesis of AEC syndrome 
One of the crucial information that would be required to fully understand 
the pathogenesis of AEC syndrome is the function of the SAM domain. 
Yeast two-hybrid screenings (Y2H) in which p63 was used as bait, reported 
that ABBP1, a splicing regulator, binds to the SAM domain (67). Physical 
association of p63 and ABBP1 induced alternative splicing of the Fgfr2 
(fibroblast growth factor receptor 2) toward the Ksam isoform essential for 
epithelial differentiation. AEC mutations were reported to disrupt p63-
ABBP1 association with a consequent decrease in Ksam isoform (67). To 
test the possibility that Fgfr2 may undergo differential splicing in p63
+/L514F
 
mutant mice compared to wild-type, we performed a Real time PCR 
analysis on both mutant and wt mice. We did not observed any difference 
either in isoform of Fgfr2 Bek (the prevalent isoform in dermis) or in Ksam 
(Fig.22). 
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Figure 22. Expression of Fgfr2 isoforms in p63
+/L514F 
mice . Ksam (black 
bars) and Fgfr2!Bek (white bars) splicing isoforms were measured at the 
mRNA level by real time RT!PCR in p63
+/L514F
  and wild!type (WT) 
epidermis at P0 stage. As control these isoforms were measured in mouse 
primary keratinocytes (KER), where Ksam is the only isoform expressed, 
and in wild-type dermis were the prevalent isoform is Fgfr2!Bek as 
expected.  
 
 
 
To uncover other possible pathways that may be at the basis of the 
hypoplastic skin phenotype, we considered changes in gene expression 
profile of p63
+/L514F
 versus wild-type mice and tried to correlate the 
phenotype of these mice to those of other skin models.  
Double knock-out mice for Mek1 and Mek2 display a similar hypoplastic 
phenotype due to loss of ERK1/2 phosphorylation (68). Thus, we measured 
levels of phosphorylated ERK1-2 by immunoblotting on keratinocytes 
isolated from p63
+/L514F 
and wild-type mice under basal condition and after 
induction of MAPK pathway with insulin-like growth factor 2 (IGF2). No 
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differences between wild-type and p63
+/L514F
 keratinocytes could be 
detected (Fig 22A).  
We performed immunoblotting analysis of phosphorylated ERK1-2 also on 
p63
+/L514F 
and  wild-type keratinocytes plated at  low density and with a 
medium that favors the growth of epidermal stem cells (see Materials and 
Methods). We tested three different wild-type and mutant sets recovered 
after one week of culture. Also this subpopulation of cells that might be 
responsible for the epidermal phenotype of p63
+/L514F
 mice, did not display 
differences in phosphorylation of ERK1-2 (Fig 22B). 
 
 
 
Figure 22. Levels of ERK phosphorilation in p63
+/L514F 
and wild-type 
keratinocytes. A. Immunoblotting analysis of phosphorylated ERK1/2 on 
keratinocytes isolated from p63
+/L514F 
and wild-type newborn mice. Cells 
were induced with 100ng of IGF2 at different time point (10’, 30’) or left 
untreated (0). B. Immunoblotting analysis of phosphorylated ERK1/2 on 
epidermal stem cells after one week of culture. We analyzed three different 
wild-type and mutant sets. Total ERK level was used as control. 
 
 
 Among the biochemical pathways that may be involved in maintenance of 
an appropriate stem cell compartment in skin, we tested the possibility that 
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p63
+/L514F
 expression may affect the insulin/IGF signaling. This signaling 
pathway is key regulator of energy metabolism and growth. We found that 
IGF2 is strongly reduced in gene chips analysis and we confirmed this result 
in p63
+/L514F
 versus wild-type skin at mRNA and protein levels (Fig. 23A, 
B).  
 
 
 
 
Figure 23. Expression of  Igf2 in p63
+/L6514F
 mice epidermis. A. Real time 
PCR analysis of mRNA extracted from epidermis of mutant versus wild 
type mice using oligos that anneal on Igf2 gene. B. Immunoblotting analysis 
of mutant versus wild-type epidermal extracts using an antibody against the 
Igf2 protein.  
 
 
Results 
  
57 
Interestingly, it has been recently reported that mice with an epidermal 
deletion of the Igf receptor  1 (Igfr1) have a very similar hypoplastic 
phenotype with no obvious proliferation or differentiation defects (69). 
Conversely, overexpression of Igf2 results in epidermal thickening and 
increased nuclear counts in the absence of an obvious increase in cell 
proliferation (70). The phenotype of Igfr1 null epidermis has been ascribed 
to a decreased proliferative potential of epidermal stem cells. Igfr1 null 
epidermis displays a strong reduction of Krt15 expression, and a defect in 
colony-forming assay. Similar reductions were observed in p63
+/L514F
 mice 
(Fig. 16, 18) thus suggesting a strong overlap between the phenotypes of the 
two mouse models.  
We evaluated the expression of Akt, a downstream kinase of IR/IGF-1R 
signaling pathway, under basal condition and after induction of  PI3K-Akt 
pathway by treatment with IGF2. Similarly to what previously observed in 
mice with epidermal deletion of Igfr1, Akt phosphorylation remained at 
physiological levels in p63
+/L514F
 mice. However, as in mice with epidermal 
deletion of Igfr1, total levels of Akt were higher in p63
+/L514F
 mice than in 
their wild-type littermates, suggesting a compensatory mechanism. 
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Figure 22. Levels of Akt phosphorilation in p63
+/L514F 
and wild-type 
keratinocytes.A. Immunoblotting analysis of phosphorylated AKT on 
keratinocytes isolated from p63
+/L514F 
and wild-type newborn mice. Cells 
were induced with 100ng of IGF2 at different time point (10’, 30’) or left 
untreated (0). !-TUBULIN (!TUB) was used to normalize samples.  
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4. DISCUSSION 
 
p63
+/L514F
 mice constitute the first mouse model generated to study the 
pathogenesis  of AEC syndrome. This model carries a clinically relevant 
point mutation in the SAM domain of the p63 alpha isoform, and faithfully 
recapitulates the human disorder.  
In the characterization of the AEC mouse model, we essentially focused our 
attention on skin defects for their severity in AEC patients and for the 
dramatic epidermal phenotype observed in p63 null mice. We find that the 
epithelial phenotype of p63
L514F/+ 
mice is characterized by severe hypoplasia 
of epidermis and hair follicle. Our working hypothesis is that this epidermal 
hypoplasia results in the skin fragility observed in AEC mice and in 
patients. Our results indicate that skin of p63
+/L514F
 is hypoplastic in spite of 
a normal proliferation and differentiation. During this study we collected 
evidence suggesting that the skin phenotype is caused by a defect in the 
proliferative potential and/or survival of epidermal progenitor cells. This 
defect is associated with an increased apoptosis of the basal compartment of 
epidermis.  
Hypoplastic phenotype in previously described mouse models has been 
ascribed to either defective proliferation or differentiation. In particular, 
Fgfr2-IIIb
-/-
 mice and Fgf10
-/-
 mice are characterized by a severe skin 
hypoplasia, associated with cell proliferation defect (71, 72). Similarly, 
disruption of the MEK/ERK pathway results in skin hypoplasia and reduced 
cell growth (68, 73). Since p63 has an important role in epidermal 
proliferation (53, 54) we asked if a reduced proliferative potential of 
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epidermal cells could explain the reduced skin thickness. However cell 
proliferation in the basal compartment of the epidermis and hair follicle of 
p63
+/L514F
 mice was unaffected either at different stages of skin maturation 
(E13.5, E16.5, and P0) or in cultured primary keratinocytes. In addition we 
found that expression of Fgfr2 isoforms and ERK phosphorylation were 
unaffected in p63
+/L514F 
mutant mice.  
Hypoplasia could also been ascribed to a defective differentiation (74). p63 
was identified as a crucial positive regulator of epidermal stratification (17, 
55). In our mouse model differentiation occurs normally as showed by the 
correct localization and expression of differentiation markers like Krt1 and 
Krt10, Involucrin, Loricrin, and as confirmed by the permeability assay that 
demonstrate the presence of a complete skin barrier. These findings are not 
in contrast with a role of p63 in differentiation, rather suggest that only a 
subset of p63 functions are altered by the L514F heterozygous mutation. 
We collected evidence in support of an involvement of p63 in maintenance 
of the epidermal stem cell compartment. The first evidence is constitute by 
the severe epithelial phenotype of p63 null mice that has been interpreted to 
result from both lack of commitment of the immature ectoderm to the 
epidermal lineage (17), and to a defect in the proliferative potential of the 
p63-deficient epidermal progenitor cells (18). In addition, p63 is expressed 
in holoclones (colonies generated by stem cells) of human keratinocytes and 
corneal cells (75, 76). To investigate the possible mechanism of action of 
p63 in maintaining proliferative potential of epithelial stem cells, Senoo et 
al focused their attention on thymus development of p63
-/-
 mice since in this 
mouse model the epidermis is absent. They showed that the deletion of p63 
is responsible for thymus hypoplasia without affecting differentiation or 
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commitment of epithelial stem cells. By clonogenic analysis performed on 
cultured thymus epithelial cells, they demonstrated that p63-null colonies 
have a reduced number of cells compared to wild-type colonies associated 
to an increase in the rate of apoptosis of thymic epithelial cells in vivo (57). 
In agreement with studies on thymic epithelial cells, clonogenic analysis 
performed on rat epidermal keratinocytes transfected with an shRNA 
against p63 demonstrated that p63-deficient colonies are smaller than their 
wild-type counterpart (57).  
We show here that in p63
+/L514F
 mice, commitment of all epidermal lineages 
occurs properly, whereas proliferative potential/survival of epidermal stem 
cells is defective.  We estimated the number of epidermal stem cells by 
performing FACS analysis with the cell surface markers CD49f and CD71, 
on freshly isolated keratinocyte. Cells identified as CD49f
bri
/CD71
dim
 are 
putative epidermal stem cells (see Introduction). We found that this cell 
population is strongly reduced in p63
+/L514F
 mice epidermis versus wild-
type. In addition, colony-forming assay showed that colonies derived from 
p63
+/L514F
 keratinocytes have a reduced size and a different morphology 
compared to wild-type. Finally, we showed that both mRNA and protein 
levels of the putative skin stem cell marker Krt15 are strongly reduced in 
p63
+/L514F
 mice compared to wild-type. Interestingly we found a reduction 
of both at mRNA and protein levels of Krt15 in several AEC patients 
affected by different mutations. Thus our findings indicate that L514F 
heterozygous mutation does not affect epidermal stratification or 
proliferation, whereas it specifically affects stem cell compartment.  
Our data indicate that the defect in stem cell compartment is due to an 
increased rate of apoptosis in the basal layer of epidermis of newborn 
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p63
+/L514F
 compared to wild-type mice. A role of p63 in apoptosis was 
previously suggested (63-66). Rocco et al. showed that !Np63! act as a 
survival factor by inhibiting p73-dependent apoptosis (77-79). Future work 
will be required to assess whether apoptotic cells that we have detected in 
the basal layer of the mutant epidermis, belong to the pool of progenitor 
cells.  
In the attempt to uncover the molecular basis of AEC syndrome we 
hypothesize two alternative biological mechanism. Strong evidence suggests 
that the Igf receptor 1 (Igfr1) signaling pathway could be affected in AEC 
mice. It was demonstrated that IGF2, a ligand of Igfr1, is implicated in 
proliferative potential of human embryonic stem cells (80) and that its 
overexpression results in epidermal thickening and increased nuclear counts 
(70). Our microarray data indicate that p63
+/L514F
 have reduced level of Igf2. 
These data were confirmed both at mRNA and protein levels.  
In addition, mice with epidermal deletion of Igfr1 have a very similar 
hypoplastic phenotype to p63
+/L514F
 mice with no obvious proliferation or 
differentiation defects (69). Igfr1 null epidermis displays a strong reduction 
of Krt15 protein levels and a defect in colony-forming assay. Thus both the 
skin phenotypes of mice with epidermal deletion of Igfr1 and p63
+/L514F
 
mice were caused by a decreased proliferative potential of epidermal stem 
cells. Taken together these data suggest that mutations in the SAM domain 
may cause a defect in Igf2/Igfr1 signaling pathway, resulting in reduced 
stem cell proliferation potential and cell survival. 
An alternative possibility could involve the ability of !Np63! to interfere 
with p73-mediated apoptosis. The p63 and p73 proteins contain a highly 
homologous oligomerization domain (>60% identical) and are able to 
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heterodimerize (65). !Np63! was shown to inhibit p73-dependent 
transactivation both by an “off –promoter” mechanism involving 
sequestration of p73 protein and by binding to the promoter of the pro-
apoptotic gene Puma suppressing its transcription (65).  Thus, we postulate 
that in p63
+/L514F
 mice heterodimerization between p63 and p73 may be 
defective and p73 protein may be free to activate an apoptotic program in 
the basal compartment. Future experiment will be required to test this 
hypothesis on keratinocytes isolated either from wild-type or p63
+/L514F
 
mice.  
A search for interactors of the SAM domain has been performed by several 
laboratories, including ours. However, we have not been able to identify 
protein interacting with this domain. A distinct possibility is that SAM 
domain may be crucial for the formation of specific transcriptional 
complexes, involved in regulation of a subset of targets. Thus, typical 
developmental
 
defects of AEC syndrome could be caused by disruption
 
of 
these interactions rather than by alteration of direct p63 transcriptional 
targets. This hypothesis is supported by our microarray analysis indicating 
that only a subset of p63 target genes is affected by the mutation.  
In the absence of its wild-type counterpart, the L514F mutant allele causes a 
similar epithelial defect of the one observed in p63
-/-
 mice suggesting that 
epidermal defects observed in our AEC mouse model could be attributed to 
a dominant-negative effect rather than a gain-of-function. Such dominant-
negative effect could act on a subset of specific functions regulated by the 
SAM domain. Facial and limb malformation are less severe in p63
-/ L514F 
than in p63
-/-
, whereas the severe epidermal defect is identical in the two 
mouse model. Taken together these data suggest that the p63" and p63# 
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isoforms present in a single copy in the p63
-/ L514F 
mice, can partially rescue 
the limb and facial phenotype, while are unable to rescue the epidermal 
phenotype. Thus we showed that the SAM domain plays a crucial role in 
epidermal morphogenesis since p63
+/L514F
 keratinocytes, in presence of an 
intact DNA binding domain, show a deficit in the epidermal progenitor cell 
compartment.  
In conclusion, our mouse model will be useful for us and more in general 
for the scientific community engaged in this field to understand the 
pathogenesis of this complex disorder, characterize more in detail identity 
and property of epidermal stem cells and to set up clinically relevant 
treatments to alleviate skin symptoms in AEC children.  
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